Literature DB >> 22607369

Hemodynamic contribution of stem cell scaffolding in acute injured myocardium.

Ling Qian1, Winston Shim, Yacui Gu, Mohamed Shirhan, Kee Pah Lim, Lay Poh Tan, Chong Hee Lim, Yoong Kong Sin, Philip Wong.   

Abstract

Tissue-engineered scaffolds may improve experimental outcomes in cardiac cell therapy by targeted delivery of stem cells and mechanically support an infarcted left ventricular (LV) wall. We transplanted cardiomyocyte-like cells (5×10(5)) with scaffolding via epicardial patching (cell patch, n=17) or a low-dose intramyocardial hydrogel (LD hydrogel, n=18), a high-dose (5×10(6)) intramyocardial hydrogel (HD hydrogel, n=18) or transplanting a serum-free medium control (control, n=13), a blank patch (n=14), and a blank gel (n=16) for targeted cardiomyoplasty in a myocardial infarcted rat model. LV real-time hemodynamics were assessed using a 1.9-F pressure-volume catheter 7 weeks after stem cell transplantation. All mode of scaffold transplantation protected diastolic function by preserving LV wall integrity that resulted in a lower end diastolic pressure-volume relationship (EDPVR) as compared to a control medium-injected group. Moreover, epicardial patching, but not hydrogel injection, reduced ventricular wall stress with a significantly better LV end diastolic pressure (EDP: 5.3±2.4 mmHg vs. 9.6±6.9 mmHg, p<0.05) as compared to control. Furthermore, epicardial patching additionally preserved systolic function by modulating negative remodeling through restricting dilatation of the LV chamber. In comparison to control, an improved ejection fraction in the cell patch group (80.1%±5.9% vs. 67.9%±3.2%, p<0.01) was corroborated by load-independent enhancement of the end systolic pressure-volume relationship (ESPVR: 0.88±0.61 mmHg/uL vs. 0.29±0.19 mmHg/uL, p<0.05) and preload recruitable stroke work (PRSW: 68.7±26.4 mmHg vs. 15.6±16.2 mmHg, p<0.05) in systolic function. Moreover, the cell patch group (14.2±1.7 cells/high-power field vs. 7.4±1.6 cells/high power field, p<0.05) was significantly better in myocardial retention of transplanted stem cells as compared to the LD hydrogel group. Collectively, myocardial transplantation of compliant scaffolding materials alone may physically improve wall mechanics, largely independent of stem cells. However, epicardially grafted cell patch conferred added systolic contractility by improving stem cell retention and cellular alignment leading to improved LV remodeling and geometric preservation postinfarction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22607369     DOI: 10.1089/ten.TEA.2011.0591

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  10 in total

1.  Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.

Authors:  Ann C Gaffey; Minna H Chen; Chantel M Venkataraman; Alen Trubelja; Christopher B Rodell; Patrick V Dinh; George Hung; John W MacArthur; Renganaden V Soopan; Jason A Burdick; Pavan Atluri
Journal:  J Thorac Cardiovasc Surg       Date:  2015-07-17       Impact factor: 5.209

2.  Improved targeting and enhanced retention of the human, autologous, fibroblast-derived, induced, pluripotent stem cells to the sarcomeres of the infarcted myocardium with the aid of the bioengineered, heterospecific, tetravalent antibodies.

Authors:  Marek Malecki
Journal:  J Stem Cell Res Ther       Date:  2013-05-06

3.  Cell-cell interaction between vocal fold fibroblasts and bone marrow mesenchymal stromal cells in three-dimensional hyaluronan hydrogel.

Authors:  Xia Chen; Susan L Thibeault
Journal:  J Tissue Eng Regen Med       Date:  2013-05-08       Impact factor: 3.963

4.  Effect of DMSO concentration, cell density and needle gauge on the viability of cryopreserved cells in three dimensional hyaluronan hydrogel.

Authors:  Xia Chen; Susan Thibeault
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

5.  Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart.

Authors:  Ellen T Roche; Conn L Hastings; Sarah A Lewin; Dmitry Shvartsman; Yevgeny Brudno; Nikolay V Vasilyev; Fergal J O'Brien; Conor J Walsh; Garry P Duffy; David J Mooney
Journal:  Biomaterials       Date:  2014-05-23       Impact factor: 12.479

6.  Photo-Polymerization Damage Protection by Hydrogen Sulfide Donors for 3D-Cell Culture Systems Optimization.

Authors:  Silvia Buonvino; Matteo Ciocci; Dror Seliktar; Sonia Melino
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

7.  Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.

Authors:  Mahmood Khan; Yanyi Xu; Serena Hua; Jed Johnson; Andriy Belevych; Paul M L Janssen; Sandor Gyorke; Jianjun Guan; Mark G Angelos
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

8.  Epithelial-mesenchymal transition of cancer cells using bioengineered hybrid scaffold composed of hydrogel/3D-fibrous framework.

Authors:  Mintu Pal; Huizhi Chen; Bae Hoon Lee; Justin Yin Hao Lee; Yun Sheng Yip; Nguan Soon Tan; Lay Poh Tan
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

9.  iPSC-derived human mesenchymal stem cells improve myocardial strain of infarcted myocardium.

Authors:  Qingfeng Miao; Winston Shim; Nicole Tee; Sze Yun Lim; Ying Ying Chung; K P Myu Mia Ja; Ting Huay Ooi; Grace Tan; Geraldine Kong; Heming Wei; Chong Hee Lim; Yoong Kong Sin; Philip Wong
Journal:  J Cell Mol Med       Date:  2014-06-28       Impact factor: 5.310

10.  iPSC-derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium.

Authors:  K P Myu Mia Ja; Qingfeng Miao; Nicole Gui Zhen Tee; Sze Yun Lim; Manasi Nandihalli; Chrishan J A Ramachandra; Ashish Mehta; Winston Shim
Journal:  J Cell Mol Med       Date:  2015-11-27       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.